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ABSTRACT
A 22-year old woman visited the LAMB Hospital, Parbatipur, Dinajpur, Bangladesh, in February 2010, with 
exertional dyspnea for three weeks. She had had a normal vaginal delivery four months ago; 2-dimension-
al echocardiogram showed severe left ventricular dysfunction and biventricular thrombi, which resolved 
without complications after anticoagulation. Biventricular thrombosis with peripartum cardiomyopathy is 
quite a rare finding, and its clinical course and proper management is not known. No such case has previ-
ously been reported in Bangladesh. 
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INTRODUCTION
Peripartum cardiomyopathy (PPCM) is a rare car-
diac disorder which leads to heart failure in the last 
month of pregnancy or up to five months postpar-
tum (1). PPCM is associated with a hypercoagulative 
state, which can cause thromboembolic complica-
tions, such as intracardiac thrombus detected by 
2-dimensional echocardiogram. The clinical course 
and proper management of intracardiac thrombus 
with PPCM is yet to be elucidated. We report a case 
of biventricular thrombosis with PPCM, which was 
resolved with anticoagulation treatment without 
embolic complications. To the best of our knowl-
edge, this is the first report in Bangladesh.
CASE REPORT
A 22-year-old woman visited the LAMB Hospi-
tal, Parbatipur, Dinajpur, Bangladesh, in February 
2010, complaining of general weakness and exer-
tional dyspnea for three weeks. She had had a nor-
mal vaginal delivery at home four months ago and 
denied any specific history of medical illness. Her 
blood pressure was 90/60 mm Hg, pulse rate 120 
beat/min, respiration rate 24/min, and body tem-
perature 37.2 °C. The heart-beat was regular without 
any audible cardiac murmur. Fine rales were heard 
at both basal lung fields. Chest x-ray showed cardio-
megaly with bilateral pulmonary congestion (Fig. 
1). Electrocardiogram showed sinus tachycardia. 
Her haemoglobin was 12.0 g/dL, with total white 
cell count of 8,000/mm3. The platelet count was 
normal (240,000/mm3) with normal prothrombin 
time (15 seconds). Her liver enzyme was mildly 
elevated (serum aspartate transaminase–126.7 
IU/L) while her serum creatinine was normal (86.5 
µmol/L). A 2-dimensional and M-mode echocar-
diogram showed that both the ventricles were en-
larged and that the left ventricular systolic function 
was depressed (Fig. 2). The left ventricular end-
diastolic dimension was 64 mm, and the ejection 
fraction was 17%. Intracardiac thrombi were noted 
in both left and right ventricles (Fig. 3).  
Enalapril (5 mg) and furosemide (80 mg) were 
given. Warfarin (5 mg) was started in combination 
with subcutaneous heparin injection. 
On the 16th day of admission, the follow-up 
echocardiogram showed no thrombus in the left 
ventricle while the large thrombus in the right 
ventricle was still visible, unchanged in size. Her 
pulmonary congestion and clinical symptoms had 
improved despite the large thrombus in the right 
ventricle. She was discharged on her request on 
the same day. The dose of warfarin was adjusted 
to 2.5 mg daily, as the prothrombin time was pro-
longed up to 65 seconds (international normalized 
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On the 21st day, she visited the clinic for repeat 
echocardiogram. There was no visible intracardiac 
thrombus in either ventricle (Fig. 3). She came back 
to the clinic two months later without throm-
boembolic complications on anticoagulation with 
warfarin. The follow-up echocardiogram showed 
no intraventricular thrombus, although the left 
ventricular systolic function remained depressed.
DISCUSSION
PPCM is a disease of uncertain aetiology, charac-
terized by left ventricular systolic dysfunction and 
Fig. 1. Chest x-ray showing enlarged cardiac 
shadow and bilateral pulmonary oedema
Fig. 2. M-mode echocardiogram showing dila-
ted left ventricle and reduced left ven-
tricle systolic function 
symptoms of heart failure. It occurs in previously-
healthy women mainly at the end of pregnancy 
and up to five months after delivery (1). The inci-
dence of PPCM has been estimated to range from 
one case per 2,289 to one case per 4,000 livebirths 
Fig. 3. Echocardiogram showing biventricu-
lar thrombi (A, B), and the thrombi 
had disappeared on the 21st day after 
anticoagulation (C)
LV=Left ventricle; RV=Right ventricle; 
Arrow (   )=ThrombusKim DY et al. Biventricular thrombi in a woman
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in the USA, one case per 299 livebirths in Haiti, and 
one case per 1,000 livebirths in South Africa (2). 
The reason for such a variation in incidence among 
different countries remains unknown.
Ventricular thrombus, a potentially life-threaten-
ing condition, is frequently detected by echocardi-
ogram in PPCM patients with an ejection fraction 
of less than 35% (2). Patients with PPCM already 
face an increased risk of thromboembolism because 
of the procoagulant activity postpartum due to the 
elevation of factors VII, X, VIII, fibrinogen, and von 
Willebrand factor (3). Severe biventricular dysfunc-
tion, in addition to a hypercoagulable state during 
pregnancy, may increase the risk of ventricular 
thrombosis in patients with PPCM (4).
The proper management for intraventricular thr- 
ombus with PPCM is still to be elucidated. A few 
case reports showed that heparinization was ef-
fective, particularly with fresh thrombus; 3-5 days 
were taken for thrombi to dissolve (5). Recent 
thrombi are more shaggy and irregular in configu-
ration whereas organized thrombi are more cir-
cumscribed and immobile. Fresh thrombi also have 
a low echoic shadow and are non-laminar. The 
thrombi of our case seemed organized, less mobile, 
and with a regular surface on echocardiogram. An-
ticoagulation therapy with heparin and warfarin 
was effective in resolving the organized biventricu-
lar thrombi in our patient, although it took about 
three weeks for full resolution of the thrombi. The 
use of thrombolytic agents or embolectomy to treat 
intraventricular thrombi could be justified because 
of fear of embolic complications, although there is 
no consensus for patients with PPCM and ventricu-
lar thrombosis so far. 
The clinical course of PPCM varies, with 50-60% of 
patients showing complete or near-complete recov-
ery of clinical status and cardiac function, usually 
within the first six months postpartum; the re-
maining patients demonstrate either further clini-
cal deterioration, leading to cardiac transplantation 
or premature death, or persistent left ventricular 
dysfunction and chronic heart failure (6). Eventual 
recovery of left ventricular systolic function occurs 
more frequently in women who had an ejection 
fraction of greater than 30% at original diagnosis of 
PPCM (2). Our patient had a very low ejection frac-
tion without improvement in the first two months, 
which is associated with poor long-term outcome. 
Since a low ejection fraction predicts a higher risk 
of thromboembolic complications, we planned to 
continue anticoagulation until the left ventricular 
function becomes normal in our case.
Family-planning counselling is an important as-
pect of the care of patients after a diagnosis of 
PPCM. Subsequent pregnancy after a diagnosis of 
PPCM carries a higher risk of relapse if left ven-
tricular systolic function has not fully recovered 
first, and even with full recovery, some addition-
al risk of relapse remains (2). Physicians and obs-
tetricians should advise an appropriate method 
of family planning for all patients with PPCM. 
Since combined oral contraceptives increase the 
risk of thromboembolism, their use should be 
discouraged in this setting. Injectable contracep-
tives are not feasible when patients need active 
anticoagulation. Either subdermal implants or 
an intrauterine device can be an option, if male 
sterilization is culturally unacceptable. 
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